D. Lovett

发表

Linked Common Polymorphisms in the Gelatinase A Promoter Are Associated with Diminished Transcriptional Response to Estrogen and Genetic Fitness*

U. Panzer, R. Stahl, Z. Lukacs, 2003, Journal of Biological Chemistry.

The Hematopoietic Transcription Factor PU.1 Represses Gelatinase A Transcription in Glomerular Mesangial Cells*

R. Stahl, S. Harendza, D. Lovett, 2000, The Journal of Biological Chemistry.

Glomerular Mesangial Cell-specific Transactivation of Matrix Metalloproteinase 2 Transcription Is Mediated by YB-1*

A. Pollock, S. Harendza, D. Lovett, 1997, The Journal of Biological Chemistry.

The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein

R. Locksley, D. Lovett, F. T. Stevenson, 1997 .

Matrix Metalloproteinase 2 (Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation*

A. Pollock, D. Lovett, J. Turck, 1996, The Journal of Biological Chemistry.

Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis

R. Raffai, J. Karliner, D. Lovett, 2016, Journal of cardiovascular pharmacology.

The α1A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium.

A. Baker, J. Stull, P. Simpson, 2015, American journal of physiology. Heart and circulatory physiology.

Transgenic expression of matrix metalloproteinase‐2 induces coronary artery ectasia

R. Sarkar, J. Karliner, D. Lovett, 2011, International journal of experimental pathology.

Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells

S. Goldman, E. Shalev, D. Lovett, 2009, Reproductive biology and endocrinology : RB&E.

Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB.

J. Karliner, D. Lovett, M. Alfonso-Jaume, 2006, American journal of physiology. Heart and circulatory physiology.

A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription*

D. Lovett, P. Mertens, M. Alfonso-Jaume, 1998, The Journal of Biological Chemistry.

Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis

L. Feng, A. Pollock, D. Lovett, 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements.

D. Lovett, P. Mertens, M. Alfonso-Jaume, 1999, Journal of the American Society of Nephrology : JASN.

A N-terminal truncated intracellular isoform of matrix metalloproteinase-2 impairs contractility of mouse myocardium

M. Ratcliffe, A. Baker, D. Lovett, 2014, Front. Physiol..

The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.

R. Locksley, C. Fanton, D. Lovett, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.

M. Fini, D. Lovett, J. Bruce, 2006, American journal of physiology. Heart and circulatory physiology.

Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells.

C. Abrass, D. Lovett, G. Raugi, 1988, Endocrinology.

Connective Tissue Growth Factor Regulates Retinal Neovascularization through p53 Protein-dependent Transactivation of the Matrix Metalloproteinase (MMP)-2 Gene*

M. Grant, D. Lovett, B. Chaqour, 2012, The Journal of Biological Chemistry.

Transcription Factor YB-1 Mediates DNA Polymerase α Gene Expression*

D. Lovett, P. Mertens, U. Klinge, 2005, Journal of Biological Chemistry.

Transcription factor YB-1 mediates DNA polymerase alpha gene expression.

D. Lovett, P. Mertens, U. Klinge, 2005, The Journal of biological chemistry.

Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells.

D. Lovett, M. Davies, H. Marti, 1993, The Biochemical journal.

Intensity of renal support in critically ill patients with acute kidney injury (New England Journal of Medicine (2008) 359, (7-20))

B. Efron, G. Koch, M. Rocco, 2009 .

Interleukin 1: The patterns of translation and intracellular distribution support alternative secretory mechanisms

R. Locksley, D. Lovett, F. T. Stevenson, 1992, Journal of cellular physiology.

Hyperpolarized 13C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model

J. Kurhanewicz, David M. Wilson, A. Baker, 2017, NMR in biomedicine.

Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

D. Lovett, M. Alfonso-Jaume, R. Mahimkar, 2004, The Biochemical journal.

Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus

T. Hong, S. Bae, D. Lovett, 2019, PloS one.

Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.

J. Rapp, D. Lovett, W. Gasper, 2014, Journal of vascular surgery.

Nonsurgical Periodontal Therapy in CKD: Findings of the Kidney and Periodontal Disease (KAPD) Pilot Randomized Controlled Trial

N. Powe, E. Vittinghoff, K. Bibbins-Domingo, 2019, Kidney medicine.

The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

R. Locksley, D. Lovett, J. Turck, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia.

R. Sarkar, D. Lovett, Jackie G. Lee, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A Novel Intracellular Isoform of Matrix Metalloproteinase-2 Induced by Oxidative Stress Activates Innate Immunity

R. Raffai, G. Cecchini, J. Karliner, 2012, PloS one.

Evaluation of Akt/mTOR activity in muscle atrophy after rotator cuff tears in a rat model

S. Bodine, B. Feeley, D. Lovett, 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Activation of glomerular mesangial cells by the terminal membrane attack complex of complement.

K. Resch, D. Gemsa, D. Lovett, 1987, Journal of immunology.

Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture.

D. Lovett, M. Kashgarian, R. Sterzel, 1986, The American journal of pathology.

The mesangium and glomerulonephritis

D. Lovett, M. Kashgarian, R. Sterzel, 1982, Klinische Wochenschrift.

Novel intracellular N‐terminal truncated matrix metalloproteinase‐2 isoform in skeletal muscle ischemia‐reperfusion injury

D. Lovett, Xuhui Liu, S. Joshi, 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Polymeric meshes induce zonal regulation of matrix metalloproteinase‐2 gene expression by macrophages and fibroblasts

S. Dooley, D. Lovett, P. Mertens, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

R. Locksley, J. Ryan, D. Lovett, 1988, The Journal of clinical investigation.

Original article Muscle extracellular matrix degradation and contractibility following tendon rupture and disuse.

D. Lovett, Qia Zhang, Xuhui Liu, 2013, Muscles, ligaments and tendons journal.

Thrombospondin secretion by cultured human glomerular mesangial cells.

D. Lovett, G. Raugi, 1987, The American journal of pathology.

Structure and expression of the human gene for the matrix metalloproteinase matrilysin.

L. Matrisian, Z. Magbanua, S. Mcdonnell, 1994, The Journal of biological chemistry.

The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.

D. Lovett, M. Davies, J. Martin, 1988, The Biochemical journal.

Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.

D. Lovett, M. Kashgarian, L. Lee, 1994, The American journal of pathology.

Proteinases and the glomerulus: Their role in glomerular diseases

D. Lovett, M. Davies, G. Coles, 1990, Klinische Wochenschrift.

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction.

J. Karliner, D. Lovett, B. Zhu, 2007, American journal of physiology. Heart and circulatory physiology.

The receptor for interleukin 1 in plasma membranes of the human leukemia cell K 562: biological and biochemical characterization.

K. Resch, D. Gemsa, D. Lovett, 1986, Immunobiology.

Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction.

A. Baker, G. Cecchini, U. Simonis, 2007, Biochemical and biophysical research communications.

Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells.

D. Lovett, K. Bomsztyk, S. Bursten, 1991, The Journal of biological chemistry.

N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart Failure

A. Baker, R. Raffai, J. Karliner, 2013, PloS one.

α1A-Subtype adrenergic agonist therapy for the failing right ventricle.

A. Baker, P. Simpson, P. Cowley, 2017, American journal of physiology. Heart and circulatory physiology.

Discoidin Domain Receptor 2 Interacts with Src and Shc following Its Activation by Type I Collagen*

Hsin C. Lin, S. Friedman, G. Yancopoulos, 2002, The Journal of Biological Chemistry.

Neutral proteinase activity produced in vitro by cells of the glomerular mesangium.

J. Ryan, D. Lovett, M. Kashgarian, 1983, Kidney international.

Intereukin I and the Glomerular Mesangium

K. Resch, D. Gemsa, D. Lovett, 2007 .

Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.

W. Bessler, K. Resch, J. Ryan, 1988, The American journal of pathology.

Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

D. Lovett, A. Larsen, 1988, The Journal of clinical investigation.

Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.

J. Ryan, D. Lovett, R. Sterzel, 1983, Journal of immunology.

Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility.

A. Baker, P. Simpson, J. Karliner, 2006, Cardiovascular research.

Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1.

D. Gemsa, D. Lovett, M. Davies, 1986, Journal of immunology.

Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor.

K. Resch, J. Ryan, D. Gemsa, 1986, Journal of immunology.

RESEARCH ARTICLE Heart Failure: Novel Therapeutic Pathways Emerging from Basic Science (cid:2) 1A -Subtype adrenergic agonist therapy for the failing right ventricle

A. Baker, P. Simpson, P. Cowley, 2017 .

Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.

D. Lovett, M. Davies, J. Martin, 1989, Kidney international.

Role of oxidants and proteases in glomerular injury.

W. Couser, R. Lehrer, D. Lovett, 1994, Kidney international.

Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.

W. Couser, D. Lovett, M. Davies, 1992, The American journal of pathology.

Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase.

W. Couser, P. Baker, D. Lovett, 1992, Journal of the American Society of Nephrology : JASN.

The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.

A. Pollock, D. Lovett, R. Mahimkar, 2005, The Biochemical journal.

Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney.

A. Pollock, D. Lovett, W. Baricos, 2000, Journal of the American Society of Nephrology : JASN.

Proteinases and glomerular matrix turnover.

D. Lovett, M. Davies, J. Martin, 1992, Kidney international.

Intraventricular and interventricular cellular heterogeneity of inotropic responses to α(1)-adrenergic stimulation.

A. Baker, P. Simpson, Ki Wan Park, 2013, American journal of physiology. Heart and circulatory physiology.

An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.

A. Baker, Zhen J. Wang, R. Raffai, 2017, American journal of physiology. Renal physiology.

Asymmetric origins of the mature glomerular basement membrane

A. Pollock, D. Lovett, L. Lee, 1993, Journal of cellular physiology.

Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.

T. Meyer, A. Pollock, D. Lovett, 1995, The Journal of clinical investigation.

Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1).

D. Lovett, P. Mertens, Sunfa Cheng, 2002, The Biochemical journal.

Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma.

W. R. Breg, D. Lovett, R. Enriquez, 1979, The American journal of medicine.

Pharmacological inhibition of gelatinase B induction and tumor cell invasion

G. Rice, D. Lovett, J. West, 1996, International journal of cancer.

Gelatinase A is a glomerular mesangial cell growth and differentiation factor.

A. Pollock, D. Lovett, J. Turck, 1997, Kidney international.

Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.

R. Sarkar, D. Lovett, Jackie G. Lee, 2005, Journal of vascular surgery.

Particles from dialysis tubing stimulate interleukin-1 secretion by macrophages.

E. Ritz, R. Bouillon, J. Bommer, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The expression of two isoforms of matrix metalloproteinase-2 in aged mouse models of diabetes mellitus and chronic kidney disease

Dong Won Lee, Miyeun Han, S. Bae, 2018, Kidney research and clinical practice.

Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.

W. Couser, A. Pollock, D. Lovett, 1996, The Journal of clinical investigation.

Interleukin I and the glomerular mesangium. II. Monokine stimulation of mesangial cell prostanoid secretion.

K. Resch, D. Gemsa, D. Lovett, 1987, The American journal of pathology.

Lysosomal enzymes in glomerular cells of the rat.

J. Ryan, D. Lovett, M. Kashgarian, 1982, The American journal of pathology.

Matrix metalloproteinase-2 plays a critical role in overload induced skeletal muscle hypertrophy.

S. Bodine, D. Lovett, Qia Zhang, 2014, Muscles, ligaments and tendons journal.

YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis.

A. Pollock, D. Lovett, P. Mertens, 2010, Biochemical and biophysical research communications.

Reversal of right ventricular failure by chronic α1A-subtype adrenergic agonist therapy.

A. Baker, P. Simpson, P. Cowley, 2019, American journal of physiology. Heart and circulatory physiology.

Inhibition of MMP2/MMP9 After Spinal Cord Trauma Reduces Apoptosis

D. Lovett, B. Tay, A. Nauth, 2008, Spine.

Regulation of MMP-2 gene transcription in dermal wounds.

D. Lovett, P. Mertens, U. Klinge, 2007, The Journal of investigative dermatology.

Immunologic glomerular disease--new prospects for specific therapy.

D. Lovett, 1994, The Western journal of medicine.

Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function

D. Lovett, S. Joshi, J. Olson, 2015, PloS one.

Interleukin 1 and the glomerular mesangium. III. IL-1-dependent stimulation of mesangial cell protein kinase activity.

K. Resch, D. Gemsa, D. Lovett, 1988, Kidney international.

Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis.

K. Resch, D. Gemsa, D. Lovett, 1986, Journal of immunology.

Characterization of the interleukin-1-induced tyrosine phosphorylation of a 41-kDa plasma membrane protein of the human tumor cell line K 562.

K. Resch, D. Lovett, M. Szamel, 1989, European journal of biochemistry.

Cell culture approaches to the analysis of glomerular inflammation.

D. Lovett, R. Sterzel, 1986, Kidney international.

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.

D. Lovett, Sunfa Cheng, 2003, The American journal of pathology.

The prodomain of interleukin 1α interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells

A. Pollock, D. Lovett, J. Turck, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Studies on the mechanism whereby cyclosporin A inhibits T-lymphocyte activation.

K. Resch, D. Lovett, M. Szamel, 1985, Immunobiology.

mTOR regulates fatty infiltration through SREBP‐1 and PPARγ after a combined massive rotator cuff tear and suprascapular nerve injury in rats

S. Bodine, B. Feeley, D. Lovett, 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury

A. Pollock, D. Lovett, R. Mahimkar, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.

Norman Honbo, Joel S Karliner, J. Karliner, 2003, The Biochemical journal.

Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2*

S. Friedman, R. Klein, J. Labrador, 2002, The Journal of Biological Chemistry.

Combinatorial Interactions of p53, Activating Protein-2, and YB-1 with a Single Enhancer Element Regulate Gelatinase A Expression in Neoplastic Cells*

Yi Sun, D. Lovett, P. Mertens, 2002, The Journal of Biological Chemistry.

Biomaterials: Disturbing Factors in Cell Cross-Talk and Gene Regulation

P. Lynen-Jansen, Uwe Klinge, D. H. Lovett, 2007 .

Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells.

J. Floege, D. Lovett, P. Mertens, 2002, Journal of the American Society of Nephrology : JASN.

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis

T. Tan, J. Thiery, A. Scherer, 2017, Physiological reports.

Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.

R. Dahiya, D. Lovett, M. Alfonso-Jaume, 2011, Carcinogenesis.

Clear Cell Renal Cell Carcinoma is linked to þÿ �

T. Tan, J. Thiery, A. Scherer, 2022 .

Short term doxycycline treatment induces sustained improvement in myocardial infarction border zone contractility

L. Ge, D. Saloner, M. Ratcliffe, 2018, PloS one.

Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues

R. Locksley, D. Lovett, F. Stevenson, 1992, The Journal of experimental medicine.

Interleukin 1 induces specific phosphorylation of a 41 kDa plasma membrane protein from the human tumor cell line K 562.

K. Resch, D. Lovett, M. Martin, 1986, Immunobiology.

Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans.

D. Lovett, G. Raugi, G J Raugi, 1988, The American journal of pathology.

A thymocyte-activating factor derived from glomerular mesangial cells.

J. Ryan, D. Lovett, R. Sterzel, 1983, Journal of immunology.

Renin–angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis

Lingxiang Zhu, L A Criswell, L. Criswell, 2005, Genes and Immunity.

Interleukin-1 gene cluster polymorphisms predict risk of ESRD.

A. Hung, K. Johansen, Ś. Sen, 2005, Kidney international.

The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

P. Ponikowski, I. Piña, C. O'connor, 2012, Drug Safety.

Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy.

A. Baker, L. Turnbull, J. Karliner, 2008, American journal of physiology. Heart and circulatory physiology.

Myocardial injection of a thermoresponsive hydrogel with reactive oxygen species scavenger properties improves border zone contractility.

M. Ratcliffe, A. Wallace, A. Baker, 2020, Journal of biomedical materials research. Part A.

Production of an endogenous pyrogen by glomerular mesangial cells.

J. Ryan, D. Lovett, R. Sterzel, 1985, Journal of immunology.

Lipid A activation of glomerular mesangial cells: mimicry of the bioactive lipid, phosphatidic acid.

K. Resch, D. Lovett, S. Bursten, 1992, The American journal of physiology.

Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zone.

M. Ratcliffe, A. Baker, P. Simpson, 2014, American journal of physiology. Heart and circulatory physiology.

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.

C. Yeh, J. Karliner, D. Lovett, 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.

D. Lovett, F. Stevenson, S. Bursten, 1991, The American journal of pathology.

The Kidney and Periodontal Disease (KAPD) study: A pilot randomized controlled trial testing the effect of non-surgical periodontal therapy on chronic kidney disease.

N. Powe, E. Vittinghoff, K. Bibbins-Domingo, 2017, Contemporary clinical trials.

Release of Prostaglandins and Modulation of Leukocyte Functions

P. Krammer, K. Resch, D. Gemsa, 1986 .

An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease

A. Hung, K. Johansen, Ś. Sen, 2006, Human Genetics.

Associations of interleukin‐6, C‐reactive protein and serum amyloid A with mortality in haemodialysis patients

A. Hung, Ś. Sen, J. Mahnken, 2008, Nephrology.

Tissue-specific Enhancer-Promoter Interactions Regulate High Level Constitutive Expression of Matrix Metalloproteinase 2 by Glomerular Mesangial Cells (*)

A. Pollock, D. Lovett, P. Mertens, 1995, The Journal of Biological Chemistry.

Telomerase Deficiency in Bone Marrow–Derived Cells Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm Formation

D. Bruemmer, A. Daugherty, D. Lovett, 2011, Arteriosclerosis, thrombosis, and vascular biology.

The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus

Miyeun Han, S. Bae, D. Lovett, 2018, BMC Nephrology.

Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy

S. Bae, D. Lovett, Sang Soo Kim, 2017, PloS one.

Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.

D. Lovett, M. Davies, H. Marti, 1992, The Biochemical journal.